ASTH vs ICFI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 01, 2026

ASTH

60.0
AI Score
VS
ASTH Wins

ICFI

54.0
AI Score

Investment Advisor Scores

ASTH

60score
Recommendation
BUY

ICFI

54score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ASTH ICFI Winner
Forward P/E 23.0415 11.7509 ICFI
PEG Ratio 0 1.881 Tie
Revenue Growth 55.6% -10.3% ASTH
Earnings Growth 110.1% -22.2% ASTH
Tradestie Score 60.0/100 54.0/100 ASTH
Profit Margin 0.9% 4.7% ICFI
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD ASTH

Relative Price Performance (Last 90 Days)

ASTH 1M: -28.6% · 3M: +4.2% ICFI 1M: +11.7% · 3M: +12.9%

Current Technical Phase

ASTH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 28

RSI (14): 28.1 · Price: $35.56

ICFI

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.0% over 20 days), RSI 59

RSI (14): 59.3 · Price: $80.92

Fundamentals Snapshot

Metric ASTH ICFI
Market Cap
Forward P/E 10.4 10.5
Trailing P/E 60.1 17.9
Revenue (TTM)
Revenue Growth 0.6% -0.1%
Gross Margin 0.1% 0.4%
Operating Margin 0.0% 0.1%
EPS 0.61 4.51
Dividend Yield 0.01%

Frequently Asked Questions

Based on our detailed analysis, ASTH is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.